Skip to content
★ Sign in to follow
TP

Thomas P. Rice

Board Director
Director
Chemed CorpAndrx Corp /DE/
Total declarations
23
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€902k

Latest filing published 21 May 2024 for CHEMED CORP, €148k.

Filing timeline

BuySale
Thomas P. Rice

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Thomas P. Rice: trading record in brief

Filings by Thomas P. Rice span 2 companies, the busiest being Chemed Corp and Andrx Corp /DE/. We count 23 filings; the first trade dates from 27 February 2006 and the latest from 20 May 2024.

Sales make up the whole of the open-market record (3 sales, €902k). Other entries cover 18 share grants.

On 21 May 2024 came the latest disclosure, a share grant for €148k in Chemed Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thomas P. Rice

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◆
    DirectorExecutivesChemed Corp
    160,273 USD13SEC
    284 shares@ US$564.3417.3% of flowCapital StockSEC:0000950170-24-062731:0
  • ◆
    DirectorExecutivesChemed Corp
    160,433 USD13SEC
    294 shares@ US$545.6917.3% of flowcapital stockSEC:0001209191-23-029724:0
  • ◆
    DirectorExecutivesChemed Corp
    130,018 USD12SEC
    262 shares@ US$496.2514.6% of flowcapital stockSEC:0001209191-22-029534:0
  • ▼
    DirectorExecutivesChemed Corp
    388,937 USD30SEC
    841 shares@ US$462.4738.3% of flowcapital stockSEC:0001209191-21-041845:0
  • ◆
    DirectorExecutivesChemed Corp
    130,318 USD12SEC
    270 shares@ US$482.6612.6% of flowcapital stockSEC:0001209191-21-033412:0
  • ◆
    DirectorExecutivesChemed Corp
    130,134 USD12SEC
    279 shares@ US$466.4312.3% of flowcapital stockSEC:0001209191-20-030346:0
  • ◆
    DirectorExecutivesChemed Corp
    85,244 USD11SEC
    257 shares@ US$331.694.5% of flowcapital stockSEC:0001209191-19-031941:0
  • ▼
    DirectorExecutivesChemed Corp
    537,493 USD32SEC
    1,641 shares@ US$327.5427.8% of flowcapital stockSEC:0001209191-19-013957:0
  • ▼
    DirectorExecutivesChemed Corp
    117,845 USD30SEC
    359 shares@ US$328.266.1% of flowcapital stockSEC:0001209191-19-013957:1
  • ◆
    DirectorExecutivesChemed Corp
    85,106 USD11SEC
    255 shares@ US$333.754.0% of flowcapital stockSEC:0001209191-18-032525:0
  • ◆
    DirectorExecutivesChemed Corp
    85,071 USD11SEC
    418 shares@ US$203.524.2% of flowcapital stockSEC:0001209191-17-032593:0
  • ◆
    DirectorExecutivesChemed Corp
    60,102 USD11SEC
    475 shares@ US$126.532.9% of flowcapital stockSEC:0001209191-16-120703:0
  • ◆
    DirectorExecutivesChemed Corp
    60,023 USD0SEC
    493 shares@ US$121.75capital stockSEC:0001209191-15-044175:0
  • ●
    Chief Executive OfficerExecutivesAndrx Corp /DE/
    589,200 USD0SEC
    23,568 shares@ US$25.00Andrx Group Common StockSEC:0001209191-06-057952:0
  • ●
    Chief Executive OfficerExecutivesAndrx Corp /DE/
    3M USD0SEC
    112,619 shares@ US$25.00Andrx Group Common StockSEC:0001209191-06-057952:1
  • ◆
    Chief Executive OfficerExecutivesAndrx Corp /DE/
    43,921 USD0SEC
    1,854 shares@ US$23.69Andrx Group Common StockSEC:0001209191-06-024517:0
  • ◆
    Chief Executive OfficerExecutivesAndrx Corp /DE/
    0SEC
    50,000 shares0Andrx Group Common StockSEC:0001209191-06-014816:0
  • ◆
    Chief Executive OfficerExecutivesAndrx Corp /DE/
    79,833 USD0SEC
    4,327 shares@ US$18.45Andrx Group Common StockSEC:0001209191-06-014425:0

18 of 18 declarations